SCHEMBL4710535

SCHEMBL4710535

Cc1cccc(C=Cc2ccccc2C)n1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 8/20 0.62
NPC1 O15118 6/20 0.62
MEN1 O00255 6/20 0.62
KMT2A Q03164 6/20 0.62
ALDH1A1 P00352 5/20 0.62
KDM4E B2RXH2 4/20 0.62
TSHR P16473 3/20 0.62
CYP2D6 P10635 2/20 0.62
THPO P40225 2/20 0.62
HIF1A Q16665 2/20 0.62
SMN1; SMN2 Q16637 2/20 0.62
NPSR1 Q6W5P4 2/20 0.62
GRM5 P41594 1/20 0.62
GRM4 Q14833 1/20 0.62
HDAC6 Q9UBN7 1/20 0.62
CYP3A4 P08684 1/20 0.62
CYP2C9 P11712 1/20 0.62
PKM P14618 1/20 0.62
HPGD P15428 1/20 0.62
NFKB1 P19838 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4710534 1.00 RAB9A (0.62) RAB9ANPC1MEN1KMT2AALDH1A1
SCHEMBL4712658 0.84 RAB9A (0.76) RAB9ANPC1MEN1KMT2AALDH1A1
SCHEMBL4714148 0.82 ALDH1A1 (0.59) RAB9ANPC1MEN1KMT2AALDH1A1
SCHEMBL4761685 0.82 KMT2A (0.59) RAB9ANPC1MEN1KMT2AALDH1A1
SCHEMBL4711545 0.82 MEN1 (0.59) RAB9ANPC1MEN1KMT2AALDH1A1
SCHEMBL4711546 0.82 MEN1 (0.59) RAB9ANPC1MEN1KMT2AALDH1A1
SCHEMBL4713470 0.82 ALDH1A1 (0.59) RAB9ANPC1MEN1KMT2AALDH1A1
SCHEMBL4761687 0.82 KMT2A (0.59) RAB9ANPC1MEN1KMT2AALDH1A1
Hydrochloric Acid SCHEMBL16915436 0.81 MEN1 (0.57) RAB9ANPC1MEN1KMT2AALDH1A1
Hydrochloric Acid SCHEMBL16915438 0.81 MEN1 (0.57) RAB9ANPC1MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0998459-B1 PYRIDINE DERIVATIVES NOVARTIS AG (CH) 2008-04-23 EP claimed
EP-0998459-B1 PYRIDINE DERIVATIVES NOVARTIS AG (CH) 2008-04-23 EP disclosed
US-6656957-B1 Marked and selective modulating, especially antagonistic, action at human metabotropic glutamate receptors (mGluRs); treatment of disorders such as epilepsy, cerebral ischemias, especially acute ischemias, spasticity etc. NOVARTIS AG (CH) 2003-12-02 US disclosed